GILTERITINIB vs GIVOSIRAN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
GILTERITINIB vs GIVOSIRAN: Safety Overview
| Metric | GILTERITINIB | GIVOSIRAN |
|---|---|---|
| Total FAERS Reports | 3,672 | 1,224 |
| Deaths Reported | 1,014 | 32 |
| Death Rate | 27.6% | 2.6% |
| Hospitalizations | 1,407 | 595 |
| Average Patient Age | 60.8 yrs | 45.1 yrs |
| % Female Patients | 48.5% | 89.5% |
| FDA Approval Date | Nov 28, 2018 | Nov 20, 2019 |
| Manufacturer | Astellas Pharma US, Inc. | Alnylam Pharmaceuticals, Inc. |
| Route | ORAL | SUBCUTANEOUS |
| Marketing Status | Prescription | Prescription |